Live Chat

Rare or Not Rare: That is the Question for Transvaginal Mesh

The Food and Drug Administration (FDA) has been clear: transvaginal mesh complications are not rare. If you’re one of the unlucky thousands who have been injured as a result of your transvaginal mesh procedure, it may be time to talk with the legal professionals at the Dallas firm of Fears Nachawati.

 

Ironically, transvaginal mesh is supposed to be a solution rather than a problem for patients suffering from pelvic organ prolapse (POP) or stress urinary incontinence (SUI). The painful and uncomfortable reality for many patients, however, is that TVM procedures have hurt more than they’ve helped. What’s particularly troubling for some is that the amount of product information they received before making their health care decision was insufficient to appropriately warn them of the risks they might face.

 

Has a transvaginal mesh been part of your response to POP or SUI? A conversation with the attorneys at Fears Nachawati may help you consider what your next steps should be. For your free consultation, call us at 1.866.545.8364 or email mn@fnlawfirm.com

Categories
Drug Litigation

Rare or Not Rare: That is the Question for Transvaginal Mesh